Dr. Prestwich created and co-founded the new Spinout Space in Spokane program. sp³nw is a regional startup up that launches life science companies and helps them translate their innovations into products that transform health care and improve people’s lives.
President’s Distinguished Professor, Washington State University
Dr. Prestwich is currently the President’s Distinguished Professor, working at Washington State University’s Health Sciences Spokane campus.
WSU Entrepreneurial Faculty Ambassadors
Dr. Prestwich was founding director of WSU’s Entrepreneurial Faculty Ambassador program.
Presidential Professor, Medicinal Chemistry
Dr. Prestwich was Presidential Professor and Chair, Department of Medicinal Chemistry, College of Pharmacy, from 1996 – 2000. He continued as faculty in the department until reaching Emeritus status in 2018. He started and led two State of Utah Centers of Excellence: Center for Cell Signaling, 1997-2002, and Center for Therapeutic Biomaterials, 2003 – 2007.
Entrepreneurial Faculty Scholars (EFS)
Dr. Prestwich was the President’s Special Assistant for Entrepreneurship at the University of Utah from 2006-2018 and founded and directed the Entrepreneurial Faculty Scholars program.
Our unsurpassed commitment to client partnership has been consistently proven in the marketplace. We are recognized for supplying the highest quality products and continually investing in driving and supporting market growth. For over 25 years, our cutting-edge R&D has empowered us to develop unique value-driven solutions to meet the innovation needs of our clients.
Shasqi has created a new way to deliver drugs in the body. Our proprietary local drug activation technology allows delivery of more drug to the tumor with fewer side effects.
C-Doctor
C-DOCTOR represents a partnership among several California institutions, which joined forces after the funding of R34 grants from the National Institute of Dental & Craniofacial Research to teams headed by faculty at USC, UC San Francisco/Berkeley/Davis, and UCLA & Stanford.
Welcome to Echelon Biosciences. At Echelon, we strive to leverage our expertise in organic chemistry and assay development to create only the best reagents for biological and drug discovery research.
Our aim is to simplify the process of basic research and keep scientists moving forward.
Valitor, Inc. has developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity.
At Echelon, our goal is to be a global leader in supplying biochemical reagents, assays, and screening services to further academic research and pharmaceutical development. Echelon has always been committed to making, testing, and supporting quality reagents and providing superior service. We value integrity in business and strive to keep our focus on our customer’s needs so they can continue to do incredible research!
GlycoMira is developing synthetic glycosaminoglycan-based therapeutics that modulate the innate immune molecules. Our technology has the potential to address tremendous unmet needs for radiation oncology and chronic respiratory indications. With private investments, Utah state, and federal government grant awards from the National Institutes of Health, GlycoMira has demonstrated safety and efficacy of its lead drug candidate against a broad spectrum of inflammatory diseases.
We are singularly dedicated to helping companion animals enjoy complete comfort each and every day with novel solutions that provide exceptional comfort in extraordinary ways. Our love for our pets is anything but ordinary so we proactively look for solutions that go above and beyond. Just like they do.
